Clinical Trials

NCT07691450 | NOT_YET_RECRUITING | PHASE1
40 participants

Belinostat in Combination With Azacitidine or Pralatrexate for the Treatment of Relapse or Refractory T-cell Lymphoma

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-09
Start Date:
2027-01-03
Completion:
2029-11-24
Conditions
  • Recurrent Anaplastic Large Cell Lymphoma
  • Recurrent Enteropathy-Associated T-Cell Lymphoma
  • Recurrent Follicular Helper T-Cell Lymphoma
  • Recurrent Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type
  • Recurrent Follicular Helper T-Cell Lymphoma, Follicular-Type
  • Recurrent Follicular Helper T-Cell Lymphoma, Not Otherwise Specified
  • Recurrent Hepatosplenic T-Cell Lymphoma
  • Recurrent Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma
  • Recurrent Monomorphic Epitheliotropic Intestinal T-cell Lymphoma
  • Recurrent Peripheral T-Cell Lymphoma, Not Otherwise Specified
  • Recurrent Primary Cutaneous CD8-Positive Aggressive Epidermotropic Cytotoxic T-Cell Lymphoma
  • Recurrent Primary Cutaneous Gamma-Delta T-Cell Lymphoma
  • Recurrent Subcutaneous Panniculitis-Like T-Cell Lymphoma
  • Refractory Anaplastic Large Cell Lymphoma
  • Refractory Enteropathy-Associated T-Cell Lymphoma
  • Refractory Follicular Helper T-Cell Lymphoma
  • Refractory Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type
  • Refractory Follicular Helper T-Cell Lymphoma, Follicular-Type
  • Refractory Follicular Helper T-Cell Lymphoma, Not Otherwise Specified
  • Refractory Hepatosplenic T-Cell Lymphoma
  • Refractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma
  • Refractory Monomorphic Epitheliotropic Intestinal T-cell Lymphoma
  • Refractory Peripheral T-Cell Lymphoma, Not Otherwise Specified
  • Refractory Primary Cutaneous CD8-Positive Aggressive Epidermotropic Cytotoxic T-Cell Lymphoma
  • Refractory Primary Cutaneous Gamma-Delta T-Cell Lymphoma
  • Refractory Subcutaneous Panniculitis-Like T-Cell Lymphoma
Interventions
  • DRUG
  • PROCEDURE
  • OTHER
No Results Yet
NCT07690267 | RECRUITING
9600 participants

Continuous Vital Sign Monitoring in a Surgical Ward

Study Type:
OBSERVATIONAL
Last Updated:
2026-07-09
Start Date:
2025-09-01
Completion:
2026-10-01
Conditions
  • Patient Monitoring
  • Wearable Devices
  • Telemonitoring
  • Patient Safety
  • Patient Deterioration
  • Nurses
  • Healthcare Professionals
  • Work-related Outcomes
  • Implementation
  • Implementation Research
Interventions
  • OTHER
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page